Trial · NCT01010217
Adverse events435
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 435
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Acute renal failure | Renal and urinary disorders | Haplo Arm | 4 | 84 | |
| other | Acute renal failure | Renal and urinary disorders | 1AgMM Related/Unrelated Donors | 5 | 51 | |
| other | Acute renal failure | Renal and urinary disorders | MUD Donor | 3 | 21 | |
| other | Acute renal failure | Renal and urinary disorders | Second Transplant | 0 | 6 | |
| other | Acute renal failure | Renal and urinary disorders | Myelofibrosis | 1 | 3 | |
| other | Altered mental status | Nervous system disorders | Haplo Arm | 4 | 84 | |
| other | Altered mental status | Nervous system disorders | 1AgMM Related/Unrelated Donors | 3 | 51 | |
| other | Altered mental status | Nervous system disorders | MUD Donor | 2 | 21 | |
| other | Altered mental status | Nervous system disorders | Second Transplant | 0 | 6 | |
| other | Altered mental status | Nervous system disorders | Myelofibrosis | 0 | 3 | |
| other | Ascites | Gastrointestinal disorders | Haplo Arm | 2 | 84 | |
| other | Ascites | Gastrointestinal disorders | 1AgMM Related/Unrelated Donors | 0 | 51 | |
| other | Ascites | Gastrointestinal disorders | MUD Donor | 0 | 21 | |
| other | Ascites | Gastrointestinal disorders | Second Transplant | 0 | 6 | |
| other | Ascites | Gastrointestinal disorders | Myelofibrosis | 0 | 3 | |
| other | Autoimmune hemolytic anemia | Blood and lymphatic system disorders | Haplo Arm | 1 | 84 | |
| other | Autoimmune hemolytic anemia | Blood and lymphatic system disorders | 1AgMM Related/Unrelated Donors | 0 | 51 | |
| other | Autoimmune hemolytic anemia | Blood and lymphatic system disorders | MUD Donor | 0 | 21 | |
| other | Autoimmune hemolytic anemia | Blood and lymphatic system disorders | Second Transplant | 0 | 6 | |
| other | Autoimmune hemolytic anemia | Blood and lymphatic system disorders | Myelofibrosis | 0 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01010217/events